CXCL8 and Ito hypomelanosis: In addition, a recent single-center cohort study from Austria found that in a high-risk cohort of adult patients with underlying hematological malignancy and suspected IPA, of which the majority were receiving anti-mold prophylaxis at the time of BALF and serum sampling, IL-8 was the most reliable blood biomarker in those with IA and IMI, compared to controls, when a high cut-off was used, and exhibited close-to-perfect performance when combined with either the BALF Lateral Flow Device Test (LFD) or BALF Aspergillus PCR [9].